Skip to main content
. 2011 Jul 15;9:110. doi: 10.1186/1479-5876-9-110

Table 3.

Estimated frequency of high modality in major hematological patient populations.

Tumor Type >2n >3n Total Cases
AML 4.6% 1.5% 14,611
B-ALL 25.0% 2.0% 3,769
NHL - B-Cell 14.8% 8.2% 3,542
NHL - T-Cell 7.2% 5.1% 1,497
Hodgkins 48.8% 30.3% 244
T-ALL 5.9% 3.5% 1,130
Myeloma 39.8% 8.3% 1,561